Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety.
Konno S, Thanigaimalai P, Yamamoto T, Nakada K, Kakiuchi R, Takayama K, Yamazaki Y, Yakushiji F, Akaji K, Kiso Y, Kawasaki Y, Chen SE, Freire E, Hayashi Y.
Konno S, et al. Among authors: takayama k.
Bioorg Med Chem. 2013 Jan 15;21(2):412-24. doi: 10.1016/j.bmc.2012.11.017. Epub 2012 Nov 24.
Bioorg Med Chem. 2013.
PMID: 23245752
Free PMC article.